MedPath
NMPA Approval

Ondansetron Hydrochloride Injection

国药准字HJ20240017

April 30, 2024

Drug Information

盐酸昂丹司琼注射液

注射剂

2ml﹕4mg(按C₁₈H₁₉N₃O计)

化学药品

April 30, 2024

April 29, 2029

Company Information

Applicant Company

Sy. No.143 to 148, 150 & 151, Near Gandimaisamma Cross Roads, D.P. Pally, Dundigal Post, Dundigal Gandimaisamma (M), Medchal Malkajgiri(D), Hyderabad 500043, TS, INDIA.

Manufacturing Company

Unit-II, Plot. No. 42 to 52, Sy No.166, 171, 172 & 177, Phase-III, TSIIC, Pashamylaram(V), Patancheru(M), Sangareddy(D) - 502307, TS, INDIA.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

盐酸昂丹司琼注射液 - NMPA 批准文号 | MedPath